Scientific Advisory Board

Dr. Wian de Jongh

Dr. de Jongh has a MSc (cum laude) in Chemical Engineering from the University of Stellenbosch, South Africa and holds a PhD in Biotechnology from the Technical University of Denmark. He was furthermore awarded an affiliated associate professorship at DTU in 2017.

Dr. de Jongh, CEO of AdaptVac ApS, is an expert within advanced cell line genetic engineering and applied metabolic engineering targeting improved production characteristics. Dr. de Jongh has significant experience from the pharmaceutical industry within molecular biology, cell line development, project management, upstream process development, process scale-up, regulatory systems and transfer to cGMP manufacturing.

Dr. de Jongh was instrumental in the development of the ExpreS2 technology. He has served on the steering committee and as project manager on several larger grant-funded projects. Dr. de Jongh was employed by the company from 2011 to 2020, and has been the acting CEO and board member of AdaptVac ApS since 2017. Dr. de Jongh is a co-founder of ExpreS2ion Biotechnologies ApS.